03587nam 22006853u 450 99633908920331620230721021237.01-282-09391-697866120939131-84692-601-7(CKB)1000000000748600(EBL)434065(OCoLC)666931928(SSID)ssj0000389374(PQKBManifestationID)12156676(PQKBTitleCode)TC0000389374(PQKBWorkID)10444627(PQKB)10540505(SSID)ssj0000388986(PQKBManifestationID)11321474(PQKBTitleCode)TC0000388986(PQKBWorkID)10444858(PQKB)11683538(MiAaPQ)EBC434065(MiAaPQ)EBC4950748(Au-PeEL)EBL4950748(CaONFJC)MIL209391(OCoLC)965934893(EXLCZ)99100000000074860020130418d2009|||| u|| |engur|n|---|||||txtccrTherapeutic Strategies in Lipid Disorders[electronic resource]Oxford Atlas Medical Publishing Ltd20091 online resource (282 p.)Therapeutic StrategiesDescription based upon print version of record.1-84692-034-5 Contents; Editorand Contributors; Foreword; Chapter 1: A global view of cardiovascular risk factors; Chapter 2: Low-density lipoprotein cholesterol as a therapeutic target; Chapter 3: High-density lipoprotein as a therapeutic target; Chapter 4: Apolipoprotein B in the therapy of atherogenic dyslipoproteinaemias; Chapter 5: Management of coronary heart disease patients; Chapter 6: Stroke and transient ischaemic attack prevention; Chapter 7: Diabetes and the metabolic syndrome; Chapter 8: Hypertension; Chapter 9: Treatment of familial hypercholesterolaemiaChapter 10: Lipid lowering in chronic kidney diseaseChapter 11: Statins and heart failure; Chapter 12: Absolute risk assessment in the general population; Chapter 13: Pleiotropic effects of statins and potential new indications; Chapter 14: The role of imaging endpoints in clinical trials; Chapter 15: Biomarkers in cardiovascular disease; Chapter 16: Novel lipid-modifying agents; Chapter 17: The enhanced evidence base and translation into improved outcomes; Abbreviations; IndexLipid disorders are now recognised as a diverse group of diseases that together represent one of the foremost risk factors for cardiovascular disease in general. Frequently present in association with other chronic illnesses such as hypertension, diabetes, and obesity, lipid disorders are a key therapeutic target for clinicians.This book examines the causes and consequences of lipid disorders, and the treatments available. Special chapters are dedicated to the associations between lipid disorders and other conditions, for example cerebrovascular disease and heart failure, as well as the wider Therapeutic StrategiesLipids -- Metabolism -- DisordersLipids -- MetabolismMedicineLipids -- Metabolism -- Disorders.Lipids -- Metabolism.Medicine.616.3997Tonkin AM1019265AU-PeELAU-PeELAU-PeELBOOK996339089203316Therapeutic Strategies in Lipid Disorders2401978UNISA